Independent news and analysis for executives, clinicians, and technology leaders — every story from the HealthMatics desk.
71 stories across all topics
Amazon, Google and other self-funded employers have joined CMS' voluntary prior authorization pledge, but ERISA plans sit outside the federal rule, so the milestones only bind through ASO and TPA contracts.
Q3 2026 earnings show health systems deliberately shrinking hospital counts, and the hard part is not the sale price but the stranded overhead, EHR separation and referral loss that follow.
Epic's forthcoming Connectors tool will let its AI agents complete work inside other vendors' systems, raising audit, liability and approval questions most health systems have not written into contracts.
Capital is concentrating into a few AI-native platforms while M&A stays flat and the IPO window stays shut, leaving health systems exposed to mid-contract failure in scheduling, monitoring and virtual care.
The newest breaches hit labs, distributors and revenue-cycle software instead of hospital networks, producing zero clinical downtime and maximum legal exposure that incident response plans were never built to handle.
The first publicly announced pembrolizumab biosimilar is under FDA review just as Merck accelerates subcutaneous conversion abroad, leaving oncology service lines roughly 18 months to model two very different futures.
KFF's 2026 benchmark survey shows worker contributions for family coverage rising 9% against 5% premium growth, pushing payers toward network and site-of-service levers for 2027 contracting.
Revenue is growing and margins are not, and rating actions are clustering in systems that cannot buy scale, pushing days cash on hand ahead of operating margin as the metric boards should watch.
ASTP/ONC's deregulatory package would retire roughly half the Health IT Certification Program's criteria while narrowing information blocking exceptions, leaving hospital IT, informatics and compliance teams to absorb validation work vendors once attested to.
Automated intake is scaling into enterprise virtual front doors faster than the governance, liability and reimbursement frameworks around it, leaving health systems holding standard-of-care exposure they did not fully price.
Oracle Health's victim count has climbed tenfold to nearly 20 million since July 2025, and the hospitals that used Cerner systems, not the vendor, are the ones mailing the letters.
Fresh scrutiny of industry ties among FDA adcomm members turns a once-predictable regulatory milestone into a variable that payers, P&T committees and commercial teams now have to price in.
Fifteen parent insurers have capped enrollment on 65 Medicare Advantage plans for 2027, a quiet capacity limit that can close plans weeks before the December 7 deadline and scramble payer-mix forecasts.
CMS rulemaking on state-directed payments is moving faster and cutting deeper than the statute Congress scored, and exposure is concentrated in a handful of high-SDP states.
Health systems are stacking AI governance, data strategy and digital ownership onto the CIO job instead of hiring around it, raising hard questions about budget, authority and EHR vendor dependency.
CMS has lowered the time thresholds for billing RPM while moving to restrict third-party monitoring arrangements, turning what looks like a coding update into a staffing and procurement decision.
Attack volume against health systems roughly doubled year over year in the third quarter after rising just 14% in the first half, leaving FY security plans built on stale assumptions.
A two-week wave of obesity, bispecific and ADC deals shows US and EU drugmakers buying their next assets from Chinese biotechs, and the effects will land on pharmacy budgets by 2028.
HHS finalized an overhaul of insurer price transparency reporting in early October, pushing machine-readable files out of compliance checklists and into payer data governance budgets for 2027.
Becker's count of hospitals closing departments or ending services hit 66 in early October, and the decisions increasingly come from the CFO's office rather than a board-approved strategy framework.
Health systems are scoring revenue cycle automation on work queues cleared rather than dollars collected, and new survey data suggests almost none have connected the two before FY27 budget season.
A new national coalition is pushing federal legislation on cross-state care just as health systems and payers scale centralized virtual operations that cannot legally extend past state lines.
OCR settled two 2026 ransomware cases with self-funded group health plans for a combined $695,000, pushing HIPAA liability onto HR committees and boards rather than the clinical security team alone.
PhRMA's Oct. 7 lawsuit against CMS puts the Part B most-favored-nation demonstration on a court calendar, forcing hospital pharmacy and finance leaders into dual-track budgeting for 2027 and 2028.
CMS rated 508 MA-PD contracts for 2027, and half-star moves on single large contracts repriced 2028 bonus payments, bid strategy and provider network leverage within hours of the release.
CMS cut Medicare payments for 2,334 hospitals starting Oct. 1, the first cycle to count Medicare Advantage patients in the measure and the first to shorten the lookback to two years.
Health systems are quietly declining vendor-shipped AI features inside the EHR, and the deferral decision is becoming the clearest test of whether a governance program actually works.
CMS wants new BB and BC modifiers on virtual visits, turning every platform-delivered encounter into traceable claims data that auditors, compliance teams and revenue cycle leaders will have to defend.
The Senate advanced a bipartisan healthcare cybersecurity bill in the same week reports confirmed the HIPAA Security Rule overhaul will not be finalized soon, inverting the compliance sequence most health systems budgeted against.
HRSA has approved 10 manufacturers for the 340B rebate pilot, flipping covered entities from an upfront discount to a back-end rebate and turning a pricing debate into a working-capital problem.
Mercer projects the biggest employer health benefit cost increase in more than two decades, while federal enrollees face a 10.9% premium hike, forcing payers to redesign plans rather than absorb trend.
Hospitals are trimming administrative and middle-management layers to protect clinical FTE budgets, but vacancy and turnover data suggest the savings may be partly reclaimed by premium labor and recruitment lag.
CMS has finalized a rule standardizing electronic documentation submission for claims, adding a second interoperability build on top of unfinished CMS-0057 work and a shrinking IT leadership bench.
Late-2026 digital health capital is moving toward the plumbing layer of care delivery, and that shift changes how CIOs, CFOs and CMOs evaluate telehealth contracts, concentration risk and switching costs.
Health systems face 72-hour federal incident reporting and 24-hour ransom payment disclosure at the same moment the statutory cover for peer threat sharing has expired, leaving counsel and boards to reconcile the gap.
A temporary Medicare demonstration created a 700,000-patient obesity cohort in under 90 days, concentrating 70% of new starts with one manufacturer and resetting what health systems must staff and negotiate for 2027.
A six-week federal window, a returning subsidy cliff and a median 15% requested rate increase land together on Nov. 1, leaving payers to absorb the churn with half the runway.
Kaufman Hall's latest flash report shows year-to-date operating margins sliding to 1.4% in July as outpatient activity cooled, arriving just as CFOs lock in CY2027 volume assumptions.
January 1, 2027 is the hard date for four payer FHIR APIs, but health systems that cannot consume them inside EHR workflows will see none of the promised prior authorization relief.
Five years of federal certainty gives health systems room to build owned virtual care infrastructure, just as CMS signals it will stop paying for remote monitoring delivered by third-party vendors.
The 2026 incident pattern shows the operational damage of a ransomware attack lands next door, where neighboring hospitals absorb weeks of diverted ambulances, transfers and surge volume with no contract and no cost recovery.
A narrowing pool of mega-acquirers, new most-favored-nation pricing deals and China-sourced licensing are reshaping which drugs reach hospital formularies, and most 24-month forecasts have not caught up.
The community engagement rules take effect January 1, 2027, but the operational burden of exemption checks, procedural terminations and mid-year churn falls on the managed care plans holding the risk.
Trinity Health's 557-position IT cut was disclosed to Michigan labor regulators months after the outsourcing deal was announced, and it is becoming the template for 2026 back-office restructuring.
Abridge is now generally available to nurses across its health system clients and most Epic hospitals have adopted ambient tools, yet every validated outcome number still comes from physician outpatient deployments.
Congress extended Medicare telehealth payment through 2027, but DEA's authority to prescribe controlled substances without a prior in-person exam still expires Dec. 31, 2026.
Reported attacks on implanted cardiac devices, record ransomware volume and tighter FDA guidance are pushing hospital device fleets from an IT backlog item onto the enterprise risk register.
Medicare's third negotiation cycle is the first to reach physician-administered drugs, which turns a pharmacy benefit story into a provider revenue story for hospitals, infusion centers and oncology practices.
Insurers are proposing a 15% median increase for 2027 on top of a finalized 20% for 2026, and the filings say plainly that the individual-market pool is now structurally sicker.
Boards are re-underwriting 2027 construction as Fitch warns the nonprofit recovery has peaked and the lapse of enhanced ACA subsidies pushes billions in uncompensated care back onto providers.
As Epic and Oracle open agent tooling to customers, validation, monitoring and liability quietly move onto provider organizations whose AI committees were chartered to review vendor purchases, not in-house builds.
Sword Health's all-cash deal for Headspace pushes point solutions toward multi-condition platforms, forcing benefits, payer and health system leaders to reopen assignment clauses, outcome guarantees and pricing before renewal season.
With the government-wide secure-development attestation mandate gone and supply-chain risk findings up sixfold, health systems must move software assurance out of security reviews and into contracts.
The White House's newest round of most favored nation pricing agreements covers nine midsized manufacturers, shifting exposure toward specialty and rare disease products with no easy substitute.
Federal regulators pushed the HIPAA Security Rule overhaul to July 2027, but OCR settlements already treat risk analysis, asset inventories and MFA as the enforcement standard today.
Medicare's virtual care authority has lapsed and been patched at least three times in under a year, turning statutory whiplash into a permanent line item for staffing, claims and revenue cycle.
State SFY 2026 capitation certifications are arriving under CMS's latest rate development guide, and the gap between actuarial assumptions and post-redetermination member acuity is now a payer margin problem.
Heading into the Q4 2026 renewal window, insurers are initiating more network exits than hospitals are, and systems are absorbing the hit with median operating margins already negative.
The national exchange network passed one billion records in June 2026, roughly three months after 500 million, and the fastest-growing requestors are not the treating clinicians CIOs budgeted for.
Pharma's headline AI discovery partnerships now run past $1B, but cash at signing is typically $30M to $50M. Health system and payer leaders should plan for the pipeline, not the press release.
Business associates were tied to 43% of large healthcare breaches in the first half of 2026, and the HIPAA Security Rule overhaul that would have forced vendor monitoring just slipped to 2027.
Teladoc's move to tie payment to results signals that virtual care buyers will soon need baseline data, attribution rules and downside modeling before they sign another telehealth renewal.
Non-renewal notices must reach members by Oct. 1, and roughly one in ten Medicare Advantage enrollees is in a plan that disappears next year. Health systems inherit the churn.
Deal volume hit a six-year high in early 2026 and held through the second quarter, but the momentum is driven by a widening performance gap rather than a shared growth thesis.
Nine-figure Epic conversions are back on hospital capital agendas. Here is a decision framework for weighing migration against optimization, TEFCA-era exchange, and two to three years of clinical disruption.
Twenty-six companies now cover 89% of the branded drug market under voluntary MFN agreements, but SEC filings show three-year terms with sunset dates buyers cannot see.
A multi-day outage at Luminis Health pushed clinicians back to paper charts and rerouted patients, showing why restoration time, not breach count, is the number healthcare boards should be watching.
The CY 2027 Medicare physician fee schedule proposal would end payment for outsourced RPM, lower device reimbursement and consolidate codes, forcing health systems into a fast build-versus-buy decision.
Insurers have cut 11% of prior authorization requirements under the voluntary pledge, but denial rates of 12% to 18% mean the administrative burden may simply be moving downstream to appeals.
States won $10 billion in first-year awards, but most of the money is still moving toward subrecipient contracts while rural hospitals close labor and delivery units and cut staff in real time.
New UPMC and KLAS data show health systems have mainstreamed third-party AI faster than they built places to test it, leaving CIOs to own a safety burden regulators are shifting downstream.
